相关实验视频

Updated: Jul 5, 2026

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

PRERISK研究:一项随机对照试验,评估基于sFlt-1/PlGF的sFlt-1/PlGF计算器,用于怀孕前患者住院治疗

Anna C M Kluivers^1,2, Rugina I Neuman¹, Langeza Saleh²

¹Department of Internal Medicine, Division of Pharmacology and Vascular Medicine, Erasmus MC, University Medical Center, Rotterdam, the Netherlands (A.C.M. Kluivers, R.I.N., W.V., A.H.J.D.).

Hypertension (Dallas, Tex. : 1979)

|April 16, 2025

概括

用于预测妊娠前并发症的PRERISK计算器在一项试验中没有减少住院或并发症. 不建议使用这种工具进行常规查,以治疗孕前.

科学领域:

产科和妇科产科和妇科
孕产妇和胎儿医学孕产妇和胎儿医学
临床试验临床试验

背景情况:

孕前带来了显著的母胎风险.
为了评估这些风险,开发了一个预测模型 - - PRERISK计算器.
该模型整合了可溶性FMS类氨酸激酶-1/胎盘生长因子比率,妊娠年龄和尿蛋白与肌氨酸比率.

研究的目的:

评估PRERISK计算器是否可以减少孕前患者的住院费用.
为了确定使用PRERISK评分是否会影响并发症率.
评估PRERISK计算器在治疗怀疑或确诊的孕前方面的临床实用性.

主要方法:

进行了一项多中心,开放标签,随机对照试验.
怀疑或确诊孕前的妇女被随机分为干预 (PRERISK评分指导入院) 和控制 (常规护理) 组.
同一主要结局包括母胎并发症和住院率 (≤0.05).

主要成果:

在治疗意图分析 (41.6%与39.5%) 中,没有观察到组之间并发症的显著差异.
在PRERISK得分没有显著降低住院率 (23.6%对26.3%).
在每项方案分析中,干预组的并发症率更高 (47.8%与41.7%相比).

结论:

使用PRERISK得分的常规查与5%的截止值并没有降低孕前患者的住院率.
不建议使用PRERISK计算器进行例行使用,以减少产前的入院.
可能需要进一步的研究来探索替代预测模型或管理策略.

关键词:

胎盘生长因子胎盘生长因子孕产妇产前炎症 (pre-eclampsia) 是一个严重的疾病.怀孕怀孕怀孕怀孕怀孕风险评估风险评估风险评估可溶性fms类型的氨酸激酶-1可以溶解.

更多相关视频

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...